AAN 2021 | Impact of painful diabetic neuropathy on quality of life

Erika Petersen • 9 Apr 2021

AAN 2021

General

Erika Petersen, MD, University of Arkansas for Medical Sciences, Little Rock, AR, talks on the burden of painful diabetic neuropathy on the subset of patients with diabetes that suffer from this complication. The dysesthesia experienced is often unresponsive to treatment and substantially affects patient’s quality of life. This interview took place during the American Academy of Neurology (AAN) 2021 Annual Meeting.

Disclosures

Dr. Petersen is a consultant and independent contractor for Abbott/St. Jude Medical, Medtronic Neuromodulation, Nevro, and Vertos. She has grant or research support from Nevro, Neuros Medical, Saluda, and Medtronic Neuromodulation. She is on the Board of Directors, and a stock shareholder of, Synerfuse.